93 related articles for article (PubMed ID: 9117442)
1. Evidence for an intracellular activation loop in the IL-1 system.
Hofmeister R; Männel DN; Falk W
J Inflamm; 1995-1996; 47(3):151-63. PubMed ID: 9117442
[TBL] [Abstract][Full Text] [Related]
2. Internalization of interleukin 1 (IL 1) correlates with IL 1-induced IL 2 receptor expression and IL 2 secretion of EL4 thymoma cells.
Von Hoegen I; Falk W; Kojouharoff G; Krammer PH
Eur J Immunol; 1989 Feb; 19(2):329-34. PubMed ID: 2522880
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
4. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling.
Korherr C; Hofmeister R; Wesche H; Falk W
Eur J Immunol; 1997 Jan; 27(1):262-7. PubMed ID: 9022028
[TBL] [Abstract][Full Text] [Related]
5. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
6. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).
Palmer G; Trolliet S; Talabot-Ayer D; Mézin F; Magne D; Gabay C
Cytokine; 2005 Jul; 31(2):153-60. PubMed ID: 15923123
[TBL] [Abstract][Full Text] [Related]
7. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis.
Groves RW; Giri J; Sims J; Dower SK; Kupper TS
J Immunol; 1995 Apr; 154(8):4065-72. PubMed ID: 7706745
[TBL] [Abstract][Full Text] [Related]
8. Cellular trafficking of the IL-1RI-associated kinase-1 requires intact kinase activity.
Böl GF; Jurrmann N; Brigelius-Flohé R
Biochem Biophys Res Commun; 2005 Jun; 332(1):279-87. PubMed ID: 15896328
[TBL] [Abstract][Full Text] [Related]
9. Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility.
Merhi-Soussi F; Berti M; Wehrle-Haller B; Gabay C
Cytokine; 2005 Nov; 32(3-4):163-70. PubMed ID: 16246569
[TBL] [Abstract][Full Text] [Related]
10. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
Levine SJ; Wu T; Shelhamer JH
J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
[TBL] [Abstract][Full Text] [Related]
11. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
Higgins GC; Wu Y; Postlethwaite AE
J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
Mehraban F; Kasturi S
Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of type I IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes.
Ito A; Takii T; Matsumura T; Onozaki K
J Immunol; 1999 Apr; 162(7):4260-5. PubMed ID: 10201956
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon DY; Dinarello CA
J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
17. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts.
Penton-Rol G; Orlando S; Polentarutti N; Bernasconi S; Muzio M; Introna M; Mantovani A
J Immunol; 1999 Mar; 162(5):2931-8. PubMed ID: 10072543
[TBL] [Abstract][Full Text] [Related]
18. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts.
Maret M; Chicheportiche R; Dayer JM; Gabay C
Cytokine; 2004 Mar; 25(5):193-203. PubMed ID: 15036245
[TBL] [Abstract][Full Text] [Related]
19. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
Gabay C; Porter B; Fantuzzi G; Arend WP
J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase is essential for the constitutive expression of type I interleukin-1 receptor in human fibroblast cells.
Takii T; Ito A; Kawashima S; Ninomiya A; Matsumura T; Hayashi H; Onozaki K
Eur Cytokine Netw; 1999 Jun; 10(2):237-46. PubMed ID: 10400830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
